Targeted molecular-based therapy capitalizing on genes and gene products harbored in gastric and gastroesophageal adenocarcinomas may provide an additional therapeutic method of intervention in advanced tumors.5,6,11,14 The oncogene HER2/neu, located on chromosome 17q21, is a member of the Human Epidermal Growth Factor Receptor family, which regulates cellular functions, such as proliferation, dif